Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
Nature Communications|March 31, 2019
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in miceJulia Weber, Jorge de la Rosa, Carolyn S Grove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell LymphomaFranck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Nature Communications|November 7, 2023
Transcriptional reprogramming by mutated IRF4 in lymphomaNikolai Schleussner, Pierre Cauchy, Vedran Franke, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Nature Communications|September 1, 2021
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaFabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2019
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International CohortsLinus Angenendt, Christoph Röllig, Pau Montesinos, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
Blood|September 28, 2019
The whole-genome landscape of Burkitt lymphoma subtypesRazvan I Panea, Cassandra L Love, Jennifer R Shingleton, et al.
Leukemia|July 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysisJulian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch, et al.
Hemasphere|May 27, 2022
The EHA Research Roadmap: Malignant Lymphoid DiseasesMartin Dreyling, Marc André, Nicola Gökbuget, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
Nature Communications|March 31, 2019
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in miceJulia Weber, Jorge de la Rosa, Carolyn S Grove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2025
Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell LymphomaFranck Morschhauser, Gilles Salles, Laurie H Sehn, et al.
Nature Communications|November 7, 2023
Transcriptional reprogramming by mutated IRF4 in lymphomaNikolai Schleussner, Pierre Cauchy, Vedran Franke, et al.
Cancer Cell|June 4, 2026
Pathogenesis of diffuse large B cell lymphoma proteogenotypesJulius C Enssle, Björn Häupl, Arber Qoku, et al.
Nature Communications|September 1, 2021
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaFabian Frontzek, Annette M Staiger, Myroslav Zapukhlyak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2019
Chromosomal Abnormalities and Prognosis in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International CohortsLinus Angenendt, Christoph Röllig, Pau Montesinos, et al.
Nature|January 8, 2010
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphomaR Eric Davis, Vu N Ngo, Georg Lenz, et al.
Blood|September 28, 2019
The whole-genome landscape of Burkitt lymphoma subtypesRazvan I Panea, Cassandra L Love, Jennifer R Shingleton, et al.
Leukemia|July 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysisJulian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch, et al.
Hemasphere|May 27, 2022
The EHA Research Roadmap: Malignant Lymphoid DiseasesMartin Dreyling, Marc André, Nicola Gökbuget, et al.
Pageof 30